Status In progress
Technology type Diagnostic
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process EVA

Project Team

Project lead Toni Gasse

Email enquiries

External Assessment Group Centre for Reviews and Dissemination and Centre for Health Economics, University of York


Key events during the development of the guidance:

Date Update
24 May 2024 Declaration of interests
09 May 2024 In progress. Updated to EVA from DG
09 May 2024 There has been an additional delay to the draft guidance consultation for the Early Value Assessment: Artificial intelligence (AI) technologies for assessing skin lesions referred on the urgent suspected cancer pathway being circulated. Please accept our apologies, the website will be updated with any new consultation dates in due course.
18 January 2024 Committee meeting
25 October 2023 Scope published
18 October 2023 Scoping workshop
05 September 2023 - 03 October 2023 Specialist committee member recruitment
05 September 2023 Launch
24 August 2023 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on our processes and methods, please see our early value assessment interim statement.